4.0 Review

Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype?

期刊

ARTHRITIS AND RHEUMATISM
卷 65, 期 1, 页码 12-20

出版社

WILEY-BLACKWELL
DOI: 10.1002/art.37829

关键词

-

资金

  1. Netherlands Organisation for Scientific Research
  2. Dutch Arthritis Foundation (Reumafonds)
  3. UCB
  4. Novartis
  5. Roche
  6. Eli Lilly
  7. Abbott
  8. Merck
  9. Pfizer

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Rheumatology

Impact of barrier tissue inflammation and physical activity on joint homeostasis in mice

Margot Van Mechelen, Tobie Martens, Pieter Vanden Berghe, Rik Lories, Giulia R. Gulino

Summary: The study found that local induction of inflammation can trigger a systemic response, leading to splenomegaly, loss of bone mass, and bone marrow changes. Physical activity does not affect the severity of systemic inflammation, but independently impacts joint homeostasis.

RHEUMATOLOGY (2022)

Article Medicine, Research & Experimental

Real-World Efficacy and Safety of Apremilast in Belgian Patients with Psoriatic Arthritis: Results from the Prospective Observational APOLO Study

Kurt de Vlam, Adrien Nzeusseu Toukap, Marie-Joelle Kaiser, Johan Vanhoof, Philip Remans, Marthe Van den Berghe, Silvana Di Romana, Filip Van den Bosch, Rik Lories

Summary: The APOLO study findings suggest that the use of apremilast in Belgian clinical practice improves the signs and symptoms of PsA and enhances patient quality of life.

ADVANCES IN THERAPY (2022)

Article Rheumatology

Unmet need in rheumatology: reports from the Advances in Targeted Therapies meeting, 2022

Kevin L. Winthrop, John D. Isaacs, Philip J. Mease, Dimitrios T. Boumpas, Xenofon Baraliakos, Jacques-Eric Gottenberg, Stefan Siebert, Marta Mosca, Neil Basu, Dana Orange, R. Lories, Daniel Aletaha, Iain B. McInnes, Tom W. J. Huizinga, Reinhard E. Voll, Ellen M. Gravallese, Ferry C. Breedveld, Josef S. Smolen

Summary: This article summarizes the unmet clinical and scientific needs in the field of rheumatology. It highlights the importance of clinical trial design innovation and the need to better understand the natural history of rheumatic diseases. The article also identifies the specific unmet needs in different rheumatological disease-specific groups and emphasizes the importance of developing therapies and therapeutic strategies for treatment-refractory disease.

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Orthopedics

Contribution of collagen degradation and proteoglycan depletion to cartilage degeneration in primary and secondary osteoarthritis: an in silico study

S. A. Elahi, R. Castro-Vinuelas, P. Tanska, R. K. Korhonen, R. Lories, N. Famaey, I. Jonkers

Summary: In silico approach was used to study the main mechanisms of cartilage degeneration in osteoarthritis. Collagen degradation drives degenerative changes in intact and degenerated cartilage, while mechanical loading initially causes proteoglycans depletion in the presence of a focal cartilage defect.

OSTEOARTHRITIS AND CARTILAGE (2023)

Article Orthopedics

Hypoxia and Wnt signaling inversely regulate expression of chondroprotective molecule ANP32A in articular cartilage

J. Quintiens, A. De Roover, F. M. F. Cornelis, A. Escribano-Nun, A. Sermon, S. Pazmino, S. Monteagudo, R. J. Lories

Summary: This study identified the hypoxia and Wnt signaling pathways as regulators of ANP32A expression. Hypoxia increased ANP32A levels, while Wnt hyper-activation decreased ANP32A levels. The modulation of the ATM gene by hypoxia and Wnt was also observed. Maintaining hypoxia and limiting Wnt activation are important for protecting against osteoarthritis.

OSTEOARTHRITIS AND CARTILAGE (2023)

Review Rheumatology

EULAR study group on 'MHC-I-opathy': identifying disease-overarching mechanisms across disciplines and borders

Jonas J. W. Kuiper, Joerg C. Prinz, Efstratios Stratikos, Piotr Kusnierczyk, Akiko Arakawa, Sebastian Springer, Dillon Mintoff, Ivan Padjen, Russka Shumnalieva, Secil Vural, Ina Koetter, Marleen G. van de Sande, Ayse Boyvat, Joke H. de Boer, George Bertsias, Niek de Vries, Charlotte L. M. Krieckaert, Ines Leal, Natasa Vidovic Valentincic, Ilknur Tugal-Tutkun, Hanane el Khaldi Ahanach, Felicie Costantino, Simon Glatigny, Danijela Mrazovac Zimak, Fabian Loetscher, Floor G. Kerstens, Marija Bakula, Elsa Viera Sousa, Peter Boehm, Kees Bosman, Tony J. Kenna, Simon J. Powis, Maxime Breban, Ahmet Gul, John Bowes, Rik J. U. Lories, Johannes Nowatzky, Gerrit Jan Wolbink, Dennis G. McGonagle, Franktien Turkstra

Summary: The 'MHC-I-opathy' concept describes a group of inflammatory diseases with overlapping clinical manifestations and a strong genetic link to the MHC-I antigen presentation pathway. However, the understanding and treatment of these disorders is limited due to patient heterogeneity and lack of systematic investigation. Therefore, interdisciplinary collaboration is needed to decipher the underlying disease mechanisms.

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Rheumatology

Inhibition of KDM7A/B histone demethylases restores H3K79 methylation and protects against osteoarthritis

Reem Assi, Chahrazad Cherifi, Frederique M. F. Cornelis, Qiongfei Zhou, Lies Storms, Sofia Pazmino, Rodrigo Coutinho de Almeida, Ingrid Meulenbelt, Rik J. J. Lories, Silvia Monteagudo

Summary: The methylation of H3K79me is reduced in osteoarthritis. Histone demethylase families, such as Jumonji-C and KDM2/7, can increase the levels of H3K79me and targeting KDM2/7 can protect joints against osteoarthritis.

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Pharmacology & Pharmacy

Innovation in Targeted Intra-articular Therapies for Osteoarthritis

Reem Assi, Jolien Quintiens, Silvia Monteagudo, Rik J. J. Lories

Summary: Osteoarthritis is a chronic joint disease characterized by progressive damage to the joints, causing pain and loss of function. Intra-articular drug therapy has emerged as a potential treatment option, with drugs being injected directly into affected joints to optimize drug bioavailability and reduce systemic toxicity. This review explores the current landscape of intra-articular drug therapies for osteoarthritis, including established approaches and those in clinical development. Despite challenges in defining outcome measures and optimizing clinical trial set-ups, advancements in drug development and clinical trial design hold promise for successful therapies for this important disease.
Article Orthopedics

Anterior Tibiotalar Fat Pad Involvement in Ankle Osteoarthritis: MRI Features in Patients 1 Year After a Lateral Ankle Sprain

Stijn Arnaert, Paul Byttebier, Sam Van Rossom, Evie Vereecke, Ilse Jonkers, Edwin Oei, Sita M. A. Bierma-Zeinstra, Rik Lories, Marienke van Middelkoop, Stefan Clockaerts

Summary: This study investigates the characteristics of the anterior tibiotalar fat pad (ATFP) in the ankle joint after one year of an ankle sprain and its correlation with systemic factors and local articular pathology. The results suggest that age, body mass index (BMI), and sex are significantly associated with the T1 intensity of ATFP. Age, diffuse cartilage loss in the lateral talus, and Kellgren and Lawrence score in the tibiotalar joint are negatively associated with the area of ATFP. BMI is positively associated with the ATFP area.

CARTILAGE (2023)

Article Rheumatology

Extent of axial damage in psoriatic arthritis and spondyloarthritis: comparative data from the BEPAS and (Be-)GIANT multicentre cohorts

Manouk de Hooge, Alla Ishchenko, Ann-Sophie De Craemer, Serge Steinfeld, Adrien Nzeusseu, Dirk Elewaut, Rik Lories, Kurt de Vlam, Filip van den Bosch

Summary: This study aimed to examine radiographic axial damage of the sacroiliac joints and spine in patients with psoriatic arthritis (PsA) and spondyloarthritis (SpA) in private and academic Belgian practices. The data comparison between the two patient groups found that patients with SpA tend to have more severe spinal damage compared to those with PsA. In patients with PsA, the cervical spine is more often affected, while in patients with SpA, the location of syndesmophytes is more evenly distributed.

RMD OPEN (2023)

Article Rheumatology

Specific descriptions of axial involvement are associated with radiographic damage development after 2 years in psoriatic arthritis patients

Manouk de Hooge, Alla Ischenko, Serge Steinfeld, Adrien Nzeusseu, Dirk Elewaut, Rik Lories, Filip van den Bosch, Kurt De Vlam

Summary: This study investigates the association between different definitions of axial involvement and syndesmophytes development in patients with Psoriatic Arthritis (PsA). The results show that the probability of developing syndesmophytes is much higher when axial involvement is determined radiographically rather than clinically, particularly in the context of high CRP.

ANNALS OF THE RHEUMATIC DISEASES (2023)

Article Immunology

A Narrative Review of the Neurological Manifestations of Human Adenosine Deaminase 2 Deficiency

Mariia Dzhus, Lisa Ehlers, Marjon Wouters, Katrien Jansen, Rik Schrijvers, Lien De Somer, Steven Vanderschueren, Marco Baggio, Leen Moens, Benjamin Verhaaren, Rik Lories, Giorgia Bucciol, Isabelle Meyts

Summary: Deficiency of human adenosine deaminase type 2 (DADA2) is a rare autoimmune disorder characterized by vasculopathy, immune dysregulation, and hematologic abnormalities. Neurological manifestations, particularly strokes, are a significant feature of DADA2, with brain stem and deep gray matter being commonly affected. Other neurological involvements include neuropathies, focal deficits, ophthalmological findings, convulsions, and headaches. Recognizing the diverse neurological manifestations of DADA2 is crucial for accurate diagnosis and appropriate management.

JOURNAL OF CLINICAL IMMUNOLOGY (2023)

Review Rheumatology

Triple jump for the optimal management of psoriatic arthritis: diet, sleep and exercise - a review

Ennio Lubrano, Silvia Scriffignano, Kurt de Vlam, Mario Ronga, Fabio Massimo Perrotta, Rik Lories

Summary: Psoriatic arthritis (PsA) is a complex and chronic inflammatory disease that combines arthritis and psoriasis with other conditions and comorbidities. Non-pharmacological approaches such as diet modifications, improved sleep quality, and physical activity have been shown to improve the quality of life for PsA patients.

RMD OPEN (2023)

Article Cell & Tissue Engineering

Osteomodulin downregulation is associated with osteoarthritis development

Jeremie Zappia, Qiao Tong, Renee Van der Cruyssen, Frederique M. F. Cornelis, Cecile Lambert, Tiago Pinto Coelho, Juliane Grisart, Erika Kague, Rik J. Lories, Marc Muller, Dirk Elewaut, Chrissy L. Hammond, Christelle Sanchez, Yves Henrotin

Summary: Abnormal subchondral bone remodeling leading to sclerosis is a main feature of osteoarthritis. Osteomodulin (OMD), a proteoglycan, is associated with the sclerotic phenotype. This study found that OMD binds to RANKL and inhibits osteoclastogenesis, thus regulating bone remodeling and contributing to bone and cartilage homeostasis. Targeting OMD may be a promising personalized approach for osteoarthritis.

BONE RESEARCH (2023)

Meeting Abstract Orthopedics

INHIBITION OF HISTONE DEMETHYLASES AS AN APPROACH TO RESTORE DEFICIENT DOT1L ACTIVITY IN OSTEOARTHRITIS

R. Assi, C. Cherifi, F. Cornelis, R. Lories, S. Monteagudo

OSTEOARTHRITIS AND CARTILAGE (2022)

暂无数据